Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Real-World Evidence: Sponsors Will Need Prospective Process Early In Development

Executive Summary

US FDA's approach to clinical trial replication project may offer tips for sponsors looking to use real-world evidence to support drug development.

Related Content

Real-World Evidence: Observational Studies Deserve More Respect In US FDA Framework
Real-World Evidence: US FDA Framework Emphasizes Data Fitness And Study Quality
Real-World Evidence Demo Projects From US FDA To Include New Mobile App
Real-World Data Could Get Boost From Trial Replication Project


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts